| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,047 |
12,169 |
$991K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
4,367 |
4,352 |
$477K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,958 |
2,908 |
$328K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,254 |
3,250 |
$322K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,000 |
2,996 |
$311K |
| 92134 |
|
4,493 |
4,350 |
$154K |
| 92083 |
|
2,591 |
2,565 |
$139K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
604 |
603 |
$95K |
| 92060 |
|
1,056 |
1,055 |
$64K |
| 92133 |
|
1,222 |
1,210 |
$38K |
| 92015 |
Determination of refractive state |
2,601 |
2,578 |
$37K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
458 |
451 |
$34K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
290 |
268 |
$30K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
386 |
385 |
$21K |
| 99215 |
Prolong outpt/office vis |
101 |
95 |
$17K |
| 92250 |
|
410 |
403 |
$13K |
| 92002 |
|
128 |
127 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
98 |
98 |
$7K |
| 92201 |
|
262 |
140 |
$6K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
42 |
41 |
$4K |
| 92020 |
|
125 |
125 |
$3K |
| 92285 |
|
40 |
37 |
$286.94 |
| 92202 |
|
17 |
12 |
$248.45 |
| 2022F |
|
80 |
79 |
$0.00 |